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Abstract
Objective: The purpose of this study was to evaluate whether individuals consider their HCV infection to be a potentially
traumatic experience. Additionally, we investigated its association with Post-Traumatic Stress Disorder (PTSD) and the
impact of PTSD diagnosis on health-related quality of life (HRQoL) in HCV infected subjects.
Methods: We conducted a cross-sectional survey of 127 HCV-infected outpatients recruited at a University Hospital in
Salvador, Brazil. All subjects answered an orally-administered questionnaire to gather clinical and socio-demographic data.
We investigated traumatic experiences and the subject’s perception of the disease using the Trauma History Questionnaire.
PTSD and other psychiatric diagnoses were assessed through the Mini International Neuropsychiatric Interview-Brazilian
Version 5.0.0 (M.I.N.I. PLUS). HRQoL was assessed using Short-Form 36 (SF-36).
Results: Approximately 38.6% of the patients considered hepatitis C to be a traumatic experience. Of these, 60.7% had a
PTSD diagnosis. PTSD was associated with significant impairment in quality of life for individuals in seven SF-36 domains as
shown bymultivariate analysis: Role-Physical (b: 224.85; 95% CI: 242.08; 27.61), Bodily Pain (b: 219.36; 95% CI: 231.28;
27.45), General Health (b: 220.79; 95% CI: 229.65; 211.92), Vitality (b: 211.92; 95% CI: 220.74; 23.1), Social Functioning
(b: 234.73; 95% CI: 246.79; 222.68), Role-Emotional (b: 226.07; 95% CI: 244.61; 27.53), Mental Health (b: 217.46; 95% CI:
224.38; 210.54).
Conclusion: HCV is frequently a traumatic experience and it is strongly associated with PTSD diagnosis. PTSD significantly
impaired HRQoL.
Citation: Morais-de-Jesus M, Daltro-Oliveira R, Pettersen KM, Dantas-Duarte A, Amaral LD-D, et al. (2014) Hepatitis C Virus Infection as a Traumatic
Experience. PLoS ONE 9(10): e110529. doi:10.1371/journal.pone.0110529
Editor: Sharon Dekel, Harvard Medical School, United States of America
Received March 18, 2014; Accepted September 23, 2014; Published October 23, 2014
Copyright:  2014 Morais-de-Jesus et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was partially supported by the National Council of Technological and Scientific Development (CNPq): [474869/2010-5] - Edital Universal
MCT/CNPq 14/2010. The rest of the funding (totalizing 100% with the funding above) was supported by the scholarships of the Coordination for the
Improvement of Higher Level Personnel (CAPES) of the following authors: Mychelle Morais-de-Jesus; Karine Miranda Pettersen; Adriana Dantas-Duarte; Patrı´cia
Cavalcanti-Ribeiro; and Liana R. Netto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: lcq@ufba.br
Introduction
Infection with hepatitis C virus (HCV) is common throughout
the world and can result in severe liver damage and failure.
Worldwide, the most common route of HCV transmission is
intravenous drug use. The main risk factors in Brazil are blood
transfusions from non-tested blood donors, intravenous drug use,
and invasive therapies with contaminated equipment [1]. Addi-
tional risk factors of HCV infection include perinatal infection,
sexual transmission and activities with potential exposure to blood,
such as tattoo and piercing. The disease can manifest in a wide
spectrum of effects, ranging from various degrees of liver damage,
syndromes of immunological origin — such as rheumatoid
symptoms and cryoglobulinemia [2–4] — and neuropsychiatric
disorders such as depression and cognitive deficits [5–12].
Psychiatric disorders are highly prevalent among HCV-infected
patients, and have a well established effect on their well-being.
PTSD is a common, debilitating, complex syndrome which occurs
in some persons after personal exposure to a traumatic stressor or
experienced by a family member or another close associate. Some
of the main symptoms are intense fear, helplessness, persistent
avoidance of stimulus associated with the trauma, increased
arousal. [13]. ‘‘The full symptom picture must be present for over
1 month (Criterion E), and the disturbance must cause clinically
significant distress or impairment in social, occupational, or other
important areas of functioning’’ (DSM-IV). Populational studies
show the disorder’s prevalence to be around 6.8% in a study
carried out in the United States [14] and 14% in another one
carried out in Brazil [15]. PTSD is highly comorbid with many
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different medical and psychiatric illnesses and can be underesti-
mated in non-clinical populations [15–17]. It is also associated
with significantly low rates of HRQoL [18,19]. PTSD has already
been cited in HCV populations in a small number of studies, most
of which were primarily focused on other specific populations,
such as veterans, HIV co-infected persons, and persons on dialysis
[20–25].
Patients carrying the virus usually have a lower health-related
quality of life (HRQoL) when compared with a reference
population [26–28], even in the absence of severe hepatic disease
[29,30]. HRQoL is a multidimensional concept embracing an
individual’s perception of their own well-being in terms of:
physical functioning; role-physical; bodily pain; general health;
vitality; social functioning; role-emotional; and mental. This
concept is based on the World Health Organization’s definition
of health as ‘‘A state of complete physical, mental, and social well-
being and not merely the absence of disease or infirmity’’ [31].
The cause of the reduced HRQoL in asymptomatic HCV-
infected patients is not well understood and may have a
multifactorial origin. Fatigue and other symptoms of a neuropsy-
chiatric nature, like forgetfulness, depression and difficulty
concentrating, are common complaints of HCV-infected patients
[5,29]. These patients also perform more poorly on neuropsychi-
atric tests [5,32,33], suggesting the virus may act on the nervous
system. Evidence of HCV replication in the central nervous system
[34,35] supports this hypothesis. HRQoL is also improved in
patients who achieve sustained virological response after antiviral
therapy [36–38].
Another line of research considers that personal background
may affect HRQoL due to low household income, intravenous
drug use, coexistent co-morbidities, knowledge of diagnosis, and
other factors associated with acquiring the infection [39,40].
Patients with a comorbid psychiatric disorder and HCV-
infection are well documented to have reduced HRQoL [41,42].
The impact of depression on HRQoL in these patients is well-
investigated [43,44]. However, the relationship between post-
traumatic stress disorder (PTSD) and HCV infection, and their
combined consequence on HRQoL, is not well studied.
Accordingly, this study aimed to evaluate whether HCV-
infected individuals consider their HCV infection to be a
potentially traumatic event, and its association with PTSD
diagnoses. The secondary objective is to investigate the relation-
ship between PTSD diagnosis and HRQoL in HCV-infected
patients. We hypothesized that, among hepatitis C patients, there
is a perception of hepatitis C disease as a potentially traumatic




Ethical approval for this study was obtained from the local
MCO – UFBA, Institutional Review Board (IRB) (protocol 14/
2002) and it is in accordance with the Helsinki Declaration of
1975. Prior to any data collection and after a complete description
of the research, written informed consent was obtained from the
patients who agreed to participate. All subjects answered an orally-
administered questionnaire to gather clinical and socio-demo-
graphic data.
Subjects and data collection
We conducted a cross-sectional survey with chronic hepatitis C
outpatients from the University Hospital (Com-HUPES) – Federal
University of Bahia (UFBA) between June 2009 and July 2012. We
included all patients older than 18 years of age in consecutive
order. A total of 127 patients diagnosed with chronic hepatitis C
were enrolled in the study (men = 82, women = 45). The samples
were divided into ninety-nine HCV-control subjects (78%) and
twenty-eight HCV-PTSD subjects (22%).
Measurement Instruments
We used the Trauma History Questionnaire (THQ), a 24-item
self-report measurement, to assess subjects’ history of traumatic life
events. The adaptation of the scale for Portuguese met the criteria
of semantic and operational equivalences [45]. The THQ is
suitable for clinical and research environments. Traumatic
experiences were classified into the following categories: ‘‘crime-
related events’’, ‘‘general disaster and trauma’’, ‘‘physical and
sexual experiences’’, and ‘‘other events’’.
The subjects were also asked about the frequency of the event
and their ages when it occurred.
In addition to the analysis of these four types of traumatic
experience, subjects who answered ‘‘Yes’’ to question fifteen were
analyzed separately: ‘‘Have you ever had a serious or life-
threatening illness? If yes, please specify.’’ This question investi-
gated whether the patient considered hepatitis C to be a stressful,
life-threatening experience that was experienced as a potentially
traumatic event, and may be associated with PTSD.
Axis I clinical syndromes were diagnosed using the Mini
International Neuropsychiatric Interview-Brazilian Version 5.0.0
(M.I.N.I. PLUS), a short, structured diagnostic interview compat-
ible with DSM-IV and ICD-10 criteria [46].
Quality of life was assessed using Short-Form 36 (SF-36) [47].
SF-36 has been used for numerous studies all over the world in
order to assess quality of life, and has been translated and validated
in Brazil. The scale was translated and made suitable for the socio-
economic and cultural Brazilian conditions, where validity and
reproducibility were demonstrated [48]. The HRQoL was
measured by eight domains: physical functioning; role-physical;
bodily pain; general health; vitality; social functioning; role-
emotional; and mental health. The final scores in each domain
were adjusted linearly from 0 to 100 via the formulas found in SF-
36; a score of ‘‘0’’ indicates the worst health status, a score of
‘‘100’’ indicates the most favorable health status.
All interviews were conducted face-to-face by trained mental
health professionals. Kappa index (proportion of agreement
beyond probability divided by the agreement potential) was used
to obtain reliability. Every patients’ disorder was recorded and
fulfilled the criteria, according to this tool. The Kappa index
analysis among observers in the M.I.N.I. was 0.9.
Data Analysis
Statistical analysis was conducted with STATA 9.0 software.
The subjects were divided into two groups according to diagnosis
for post-traumatic stress disorder: HCV without PTSD symptoms
(HCV-control) and HCV with a diagnosis of PTSD (HCV-PTSD).
The following independent variables were selected with the
objective of performing descriptive analyses between these groups:
gender, age, civil state, occupation, transplant eligibility, presence
of medical comorbidity, number of medical comorbidities,
presence of psychiatric comorbidity and number of psychiatric
comorbidities. Chi-Square and Kruskall-Wallis tests were used to
compare categorical and continuous variables, respectively,
between HCV-control and HCV-PTSD groups.
To evaluate whether any THQ categories or a positive response
to question fifteen of THQ were independently associated with the
severity of disease (determined by transplant eligibility) or a
diagnosis of PTSD, the Pearson test was used.
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Bivariate analyses were carried out to verify the possible
differences between PTSD diagnosis and HRQoL scores through
the non-parametric Pearson test. In order to control for potential
confounding factors, a multivariate analysis was performed by a
robust linear regression model that allowed us to estimate the
increment (or decrement) yield (b) when patients with PTSD were
Table 1. Socio-demographic and clinical characteristics.
Variables HCV-control HCV-PTSD
(99 subjects) (28 subjects) p value
Gender
Male N (%) 68 (68.70) 14 (50.00)
Female N (%) 31 (31.31) 14 (50.00) 0.06*
Age Mean (SD) 53 (8.80) 52 (9.27) 0.57**
Civil state
Single N (%) 21 (21.21) 5 (17.86)
With stable partner N (%) 64 (64.65) 15 (53.57)
Divorced N (%) 12 (12.12) 4 (14.29) 0.03*
Widower N (%) 1 (1.01) 4 (14.29)
Paid occupation
Without N (%) 16 (16.67) 5 (17.86)
With N (%) 67 (69.79) 21 (75.00)
Retired N (%) 13 (13.54) 2 (7.14) 0.66*
Transplant eligibility
No N (%) 50 (50.10) 22 (78.57) 0.08*
Yes N (%) 49 (49.90) 6 (21.43)
Medical comorbidity
No N (%) 47 (47.47) 16 (57.14) 0.36*
Yes N (%) 52 (52.53) 12 (42.86)
Number of medical comorbidities Mean (SD) 0.65 (0.74) 0.75 (1.04) 0.84**
Psychiatric comorbidity
No N (%) 48 (48.48) 8 (28.57) 0.06*
Yes N (%) 51 (51.52) 20 (71.43)
Number of Psychiatric Comorbidities Mean (SD) 0.79 (1.02) 1.68 (1.56) 0.00**




Table 2. Bivariate and Multivariate Analysis of PTSD diagnosis and Quality of Life in Chronic Hepatitis C Patients.
SF-36 Domains HCV-control (99) HCV-PTSD (28) Bivaried Analysis Multivaried Models*
Mean (SD) Mean (SD) b* [CI95%] b* [CI95%]
Physicalfunctioning** 75.00 (24.32) 68.00 (27.01) 26.78 [217.76; 4.19] 26.15 [216.42; 3.11]
Role-physical** 59.94 (41.20) 36.6 (42.65) 223.34 [240.59; 26.08] 224.85 [242.08; 27.61]
Bodily pain** 73.56 (25.49) 51.5 (26.6) 222.06[233; 211.11] 219.36 [231.28; 27.45]
General health** 65.20 (19.26) 46.03 (23.39) 219.16[228.52; 29.81] 220.79 [229.65; 211.92]
Vitality** 68.41 (22.45) 49.64 (25.45) 218.77[229.07; 28.47] 211.92 [220.74; 23.1]
Social functioning** 78.94 (25.29) 42.85 (27.09) 236.08[247.17; 224.99] 234.73[246.79; 222.68]
Role-emotional** 82.63 (31.48) 46.42 ( 43.82) 236.21[253.38; 219.03] 226.07[244.61; 27.53]
Mental health** 81.14 (15.33) 56.71 (21.77) 224.42[232.93; 215.91] 217.46[224.38; 210.54]
*Standardized-b coefficients (Betas);
**Adjustment: gender, transplant eligibility, anxiety disorders, other psychiatric comorbidities, current depressive episode, past depressive episode, number of
psychiatric comorbidities.
doi:10.1371/journal.pone.0110529.t002
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compared with the reference group, patients with a negative
PTSD diagnosis.
All tests were performed using the significance level of 5%
(p#0.05).
Results
The HCV-control group was predominantly male (68.7%),
ranging in age from 23 to 68 years (mean = 5368.8); most
subjects had a stable partner (64.65%); over 69% had a paid
occupation; 49% were eligible for a liver transplant; 44.1% had
some decompensated or systemic medical comorbidity; and
50% had a psychiatric comorbidity (Table 1). On the other
hand, the HCV-PTSD group had a balanced gender variable
(14 male and 14 female), and ranged in age from 28 to 65 years
(mean = 5269.27); 53.57% were in a civil partnership; most had a
paid occupation (75%); 78.57% were not eligible for a transplant;
42.86% had a decompensated or systemic medical comorbidity;
and 71.43% had another psychiatric comorbidity. Significant
differences between groups were found through bivariate analysis
on the variables: civil state (p = 0.03) and number of psychiatric
comorbidities (p = 0.002) (Table 1).
The experiences of: ‘‘crime-related events,’’ ‘‘general disaster
and trauma,’’ and ‘‘other events’’ showed no significant association
with the development of PTSD diagnosis, unlike ‘‘physical and
sexual experiences,’’ which showed a significant association
(p = 0.019). Of all subjects, 38.6% considered hepatitis C to be a
traumatic experience. Of these, 60.7% had a PTSD diagnosis.
The perception of hepatitis C as a traumatic experience was not
associated with disease severity (needing a transplant), however it
showed a significant association with diagnosis of PTSD
(p = 0.003).
Bivariate analysis revealed a negative impact of PTSD
symptoms in the following SF-36 domains: role-physical, bodily
pain, general health, vitality, social functioning, role-emotional
and mental health. Multivariate analysis reported a negative
association in the following domains: role-physical, bodily pain,
general health, vitality, social functioning, role-emotional and
mental health, that remained significant even after adjusting for
confounding factors (Table 2).
Discussion
For our knowledge, this is the first study demonstrating HCV as
a traumatic experience strongly associated with PTSD. The
prevalence of PTSD in this sample was 28%, which is extremely
high compared to mean prevalence in the general world
population, ranging from 0% to 10.4% [49]. A recent survey
carried out in Brazil, in the two largest cities in the country, Sa˜o
Paulo and Rio de Janeiro, has estimated the prevalence of PTSD
in one year to range between 1.2% and 7.8% [50].
Our finding that a high proportion of HCV patients considered
the condition to be a potentially traumatic experience is consistent
with previous studies investigating severe acute respiratory
syndrome (SARS) [51] and myocardial infarction [52], which
are both recognized as potentially traumatic events that may lead
to post-traumatic stress syndrome. However, one limitation of the
survey is that the trauma can be influenced by the fear of death or
stress of living with an illness, since the question ‘‘Have you ever
had a serious or life-threatening illness?’’ can be interpreted
differently by each patient.
The disease severity was not significantly associated with either
the perception of hepatitis C as a traumatic experience or PTSD
diagnosis. Contrary to our expectations, disease severity showed a
tendency of negative association with PSTD diagnosis. This
unexpected result is possibly related to the small sample size, and
requires further investigation.
Even after adjusting for psychiatric comorbidities, PTSD was
associated with quality of life scores significantly lower in seven of
the eight SF-36 domains, as shown by bivariate and multivariate
analysis. Similar results were found in other studies that analyzed
quality of life in individuals diagnosed with PTSD symptoms
[53,54], including individuals with a past diagnosis of non-
recurring PTSD [55]. Therefore, PTSD is related to impaired
mental and physical health as well as increased healthcare
utilization [56].
Consistent with other studies [57], there was a higher
prevalence of PTSD diagnosis in female subjects (45.16%)
compared to males (20.58%). The prevalence of psychiatric
disorders in both HCV-control and HCV-PTSD groups was high,
especially the latter, which is in accordance with previous clinical
studies regarding individuals infected with hepatitis C [10,43]. The
HCV-PTSD samples had a prevalence of psychiatric disorders
49% higher on average than the general Brazilian population,
according to estimates from epidemiological studies of the general
population [58]. Although the majority of the studies relating
PTSD to HCV patients has been conducted with veterans and
HIV co-infected patients, this study had only two HIV co-infected
patients and no veterans.
The mode of HCV contraction is potentially an important
variable to explain some of the trauma; therefore it is important to
highlight that a previous study in the population of Bahia, Brazil,
found that the most common route of HCV infection is through
unscreened blood transfusions [42]. Furthermore, none of the
patients cited it as a traumatic experience when they were asked
about the history of potentially traumatic experiences through the
Trauma History Questionnaire.
The findings of this study should be interpreted with consid-
eration of the following methodological limitations: the cross-
sectional design may cause bias for assessment of other psychiatric
correlations with PTSD. Since stigmatization is an important
phenomenon in the HCV-infected population [59–61], patients
may, as an avoidance behavior, under-report their psychopathol-
ogy. The study design also made it impossible to know whether the
perception of HCV as a traumatic experience was impacted by
pre-existing PTSD, or was the source of the PTSD itself. Finally,
the small sample size of this study may limit the power to detect
association factors with moderate strength.
This study contributes to HCV being perceived as a traumatic
experience and, furthermore, reveals a high prevalence of PTSD
among HCV-infected patients. Our findings show that considering
a subject’s perception of HCV as a traumatic experience may help
to detect PTSD; a condition with significant HRQoL impairment.
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